openPR Logo
Press release

Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017

10-16-2017 09:10 AM CET | Health & Medicine

Press release from: Arizton Advisory & Intelligence

Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017

Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017

“Tumor Necrosis Factor Alpha (TNF-a) Inhibitors-Pipeline Insights 2017″, report provides comprehensive analysis of TNF-a drug candidates currently undergoing clinical trials. The report covers detailed drug profiles of potential TNF-a inhibitors across various clinical development phases including – discovery, pre-clinical, IND, Phase I, Phase II, Phase III and Pre-registration. Report also includes the pipeline products’ clinical trial data along with information on other development activities including technology, licensing, collaborations, acquisitions, funding, patent and USFDA & EMA designations. Report also assesses the pipeline TNF-a inhibitors by monotherapy, combination products, molecule type and route of administration. In addition to analysis on active pipeline molecules, the report also provides detailed information on the discontinued and dormant drugs.

View details: https://www.arizton.com/reports/pharma-pipeline-analysis/tumor-necrosis-factor-alpha-tnf-a-inhibitors-pipeline-insights

Key players developing potential TNF-a drug candidates have been profiled in the report. Each of the company profile provides details such as company overview, business overview, financial overview, product portfolio, business strategies, and recent developments.

Scope

Report provides in-depth insights on active TNF-a inhibitors pipeline drug candidates

Extensive pipeline product coverage with demarcation by various stages of development from NDA filings to discovery.

Provides pipeline assessment by monotherapy, combination therapy products and route of administration

Provides comparative analysis of key marketed and pipeline TNF-a inhibitors
Coverage of detailed pipeline drug profiles which includes product description, chemical information, MOA, licensors & collaborators, development partner

The report analyses key players involved in clinical research and development of the TNF-a inhibitors

Coverage of key news related to TNF-a inhibitors including major mergers and acquisitions and all product development updates such as clinical trial progression updates, regulatory updates

Related Reports

1) Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017

https://www.arizton.com/reports/pharma-pipeline-analysis/histone-deacetylase-hdac-inhibitors-pipeline-insights

2) AKT Inhibitors - Pipeline Insights 2017

https://www.arizton.com/reports/pharma-pipeline-analysis/akt-inhibitors-pipeline

About Arizton
Arizton – Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize foolproof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including –Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Arizton Advisory & Intelligence
Chicago, Illinois, 60605
Mail: enquiry@arizton.com
Call: +1-312-465-7864

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017 here

News-ID: 774108 • Views:

More Releases from Arizton Advisory & Intelligence

Precision Parts Industry to Add $376.96 Billion in Market Value by 2031 - Exclusive Insight by Arizton
Precision Parts Industry to Add $376.96 Billion in Market Value by 2031 - Exclus …
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2026-2031. Precision Parts Are Becoming a Strategic Industry to Watch The precision parts market is shifting from competing on manufacturing scale to competing on engineering capability. As demand grows across electric vehicles, aerospace, semiconductors, medical devices, and industrial equipment, OEMs are looking for suppliers that can consistently deliver complex, high-precision components while meeting strict quality and reliability standards.
Global Hand Tools Market Size to Reach USD 30.99 Billion by 2031 - Arizton
Global Hand Tools Market Size to Reach USD 30.99 Billion by 2031 - Arizton
Hand Tools Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2026-2031. The global hand tools market was valued at USD 24.75 billion in 2025 and is projected to reach USD 30.99 billion by 2031, growing at a CAGR of 3.82%, according to Arizton's latest research. The market is evolving alongside rising infrastructure investments, expanding DIY and home improvement activities, and increasing demand for durable, ergonomic,
U.S. IT Staffing Market Size to Reach USD 44.50 Billion by 2031, Growing at a CAGR of 3.01% - Arizton
U.S. IT Staffing Market Size to Reach USD 44.50 Billion by 2031, Growing at a CA …
The U.S. IT staffing landscape is undergoing a massive structural transformation. We are moving away from the era of bulk hiring generalists and entering a highly polarized, skills-first market driven by infrastructure demands and automated efficiency. Whether you are an enterprise tech leader trying to fill critical pipeline gaps, a specialized contractor navigating the new wave, or a talent strategist mapping out the next few years, understanding these numbers and trends
UAE Construction Equipment Market Size to Reach 18.15 Thousand Units by 2031 as Infrastructure Projects Drive Equipment Demand - Arizton
UAE Construction Equipment Market Size to Reach 18.15 Thousand Units by 2031 as …
UAE Construction Equipment Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2026-2031. According to recent research by Arizton, the UAE construction equipment market was estimated at 14.07 thousand units in 2025 and is expected to reach 18.15 thousand units by 2031, growing at a CAGR of 4.34% during the forecast period. Continued investments in infrastructure and urban development, along with the UAE's economic diversification strategy,

All 5 Releases


More Releases for Inhibitors

Melanoma Therapeutics Market (2025-2033) | Checkpoint Inhibitors, Myelofibrosis, …
Melanoma Therapeutics Market reached US$ 5.40 billion in 2024 and is expected to reach US$ 8.35 billion by 2032, growing at a CAGR of 5.6% during the forecast period 2025-2032. Connect with the right partners and unlock new growth opportunities today:- https://www.datamintelligence.com/partner-identification-enquiry/melanoma-therapeutics-market?kb United States: Recent Industry Developments ✅ March 2026: Bristol Myers Squibb expanded clinical pipeline for combination immunotherapy regimens integrating PD-1 and CTLA-4 inhibitors to improve response rates in advanced melanoma cases. ✅
Thymidine Phosphorylase Inhibitors Market - Breaking the Cycle: Angiogenesis Inh …
Newark, New Castle, USA: The "Thymidine Phosphorylase Inhibitors Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Thymidine Phosphorylase Inhibitors Market: https://www.growthplusreports.com/report/thymidine-phosphorylase-inhibitors-market/8826 This latest report researches the industry structure,
CGRP Inhibitors Market - Break Free from Migraine: CGRP Inhibitors Redefining Re …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global CGRP Inhibitors Market. CGRP Inhibitors Market: https://www.growthplusreports.com/report/cgrp-inhibitors-market/9155 The CGRP Inhibitors Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.
Immune Checkpoint Inhibitors Market: Current Evidence And Future Perspectives Of …
Stratagem Market Insights delivers key insights for the Immune Checkpoint Inhibitors market in its published report, which include global industry analysis, Size, Growth, Opportunities, Emerging Trends, Challenges, and Geographic Regions over the forecast period (2021-2028). In terms of revenue, the global Immune Checkpoint Inhibitors market is projected to grow at a CAGR of XX% during the forecast period, owing to several factors about which SMI offers detailed insights and forecasts
Crude Oil Flow Improvers Market by Type (Paraffin Inhibitors, Asphaltene Inhibit …
Global Crude Oil Flow Improvers Market was valued at $1,282 million in 2016, and is anticipated to reach $1,920 million, growing at a CAGR of 5.7% from 2017 to 2023. Crude oil is one of the most actively traded commodities with a stable growth rate globally. It is extracted from remote locations and needs to be transported through pipelines. Transportation of crude oil via pipeline is relatively difficult, owing to
Immune Check Point Inhibitors Market Immune Check Point Inhibitors Clinical Pipe …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Immune Checkpoint Inhibitors- Introduction to Next Generation Cancer Immunotherapy 1.1 Overview 1.2 History- From Tragedy to Breakthrough Major Immune Checkpoints Proteins 2.1 Role of Cytotoxic T lymphocyte Antigen-4 (CTLA-4) in Cancer Development 2.2 Role of Programed Cell Death Protein 1 (PD1) in Cancer Development Mechanism of Action of Immune Checkpoint Inhibitors 3.1 Cytotoxic T lymphocyte Antigen-4